The expression levels of the lnc-MRPL39-2:1 were dependent on many factors, including the NPC patients' tumor (T) stage, nodes (N) stage, and the tumor-node-metastasis (TNM) stage. This evidence concerns the gene MRPL39 and nasopharyngeal carcinoma.